S&P 500   4,228.48 (-1.29%)
DOW   33,706.74 (-0.86%)
QQQ   322.86 (-1.95%)
AAPL   171.52 (-1.51%)
MSFT   286.15 (-1.39%)
META   167.96 (-3.84%)
GOOGL   117.21 (-2.46%)
AMZN   138.23 (-2.86%)
TSLA   890.00 (-2.05%)
NVDA   178.49 (-4.92%)
NIO   19.05 (-4.32%)
BABA   89.63 (-1.22%)
AMD   95.95 (-4.47%)
T   18.43 (+0.00%)
MU   60.51 (-3.92%)
CGC   3.82 (+0.26%)
F   15.88 (-1.67%)
GE   77.72 (-1.88%)
DIS   120.14 (-2.06%)
AMC   18.02 (-6.58%)
PYPL   96.56 (-3.30%)
PFE   49.15 (+1.17%)
NFLX   241.16 (-1.64%)
S&P 500   4,228.48 (-1.29%)
DOW   33,706.74 (-0.86%)
QQQ   322.86 (-1.95%)
AAPL   171.52 (-1.51%)
MSFT   286.15 (-1.39%)
META   167.96 (-3.84%)
GOOGL   117.21 (-2.46%)
AMZN   138.23 (-2.86%)
TSLA   890.00 (-2.05%)
NVDA   178.49 (-4.92%)
NIO   19.05 (-4.32%)
BABA   89.63 (-1.22%)
AMD   95.95 (-4.47%)
T   18.43 (+0.00%)
MU   60.51 (-3.92%)
CGC   3.82 (+0.26%)
F   15.88 (-1.67%)
GE   77.72 (-1.88%)
DIS   120.14 (-2.06%)
AMC   18.02 (-6.58%)
PYPL   96.56 (-3.30%)
PFE   49.15 (+1.17%)
NFLX   241.16 (-1.64%)
S&P 500   4,228.48 (-1.29%)
DOW   33,706.74 (-0.86%)
QQQ   322.86 (-1.95%)
AAPL   171.52 (-1.51%)
MSFT   286.15 (-1.39%)
META   167.96 (-3.84%)
GOOGL   117.21 (-2.46%)
AMZN   138.23 (-2.86%)
TSLA   890.00 (-2.05%)
NVDA   178.49 (-4.92%)
NIO   19.05 (-4.32%)
BABA   89.63 (-1.22%)
AMD   95.95 (-4.47%)
T   18.43 (+0.00%)
MU   60.51 (-3.92%)
CGC   3.82 (+0.26%)
F   15.88 (-1.67%)
GE   77.72 (-1.88%)
DIS   120.14 (-2.06%)
AMC   18.02 (-6.58%)
PYPL   96.56 (-3.30%)
PFE   49.15 (+1.17%)
NFLX   241.16 (-1.64%)
S&P 500   4,228.48 (-1.29%)
DOW   33,706.74 (-0.86%)
QQQ   322.86 (-1.95%)
AAPL   171.52 (-1.51%)
MSFT   286.15 (-1.39%)
META   167.96 (-3.84%)
GOOGL   117.21 (-2.46%)
AMZN   138.23 (-2.86%)
TSLA   890.00 (-2.05%)
NVDA   178.49 (-4.92%)
NIO   19.05 (-4.32%)
BABA   89.63 (-1.22%)
AMD   95.95 (-4.47%)
T   18.43 (+0.00%)
MU   60.51 (-3.92%)
CGC   3.82 (+0.26%)
F   15.88 (-1.67%)
GE   77.72 (-1.88%)
DIS   120.14 (-2.06%)
AMC   18.02 (-6.58%)
PYPL   96.56 (-3.30%)
PFE   49.15 (+1.17%)
NFLX   241.16 (-1.64%)
NYSE:CC

Chemours - CC Stock Forecast, Price & News

$36.75
-0.44 (-1.18%)
(As of 08/19/2022 12:00 AM ET)
Add
Compare
Today's Range
$36.40
$37.15
50-Day Range
$29.39
$40.71
52-Week Range
$22.56
$44.95
Volume
1.26 million shs
Average Volume
1.72 million shs
Market Capitalization
$5.70 billion
P/E Ratio
6.86
Dividend Yield
2.69%
Price Target
$40.17

Chemours MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
9.3% Upside
$40.17 Price Target
Short Interest
Healthy
3.05% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.23mentions of Chemours in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$965,170 Sold Last Quarter
Proj. Earnings Growth
6.79%
From $5.60 to $5.98 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.39 out of 5 stars

Basic Materials Sector

71st out of 167 stocks

Chemicals & Allied Products Industry

7th out of 14 stocks

CC stock logo

About Chemours (NYSE:CC) Stock

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

Chemours Price Performance

Shares of NYSE:CC traded down $0.25 during midday trading on Friday, reaching $36.94. 6,739 shares of the stock traded hands, compared to its average volume of 1,199,935. The company has a debt-to-equity ratio of 3.01, a current ratio of 1.91 and a quick ratio of 1.27. The stock has a market capitalization of $5.73 billion, a PE ratio of 6.94, a P/E/G ratio of 0.45 and a beta of 1.82. Chemours has a one year low of $22.56 and a one year high of $44.95. The company's 50 day moving average is $33.55 and its 200 day moving average is $33.88.

Chemours (NYSE:CC - Get Rating) last posted its earnings results on Thursday, July 28th. The specialty chemicals company reported $1.89 EPS for the quarter, beating analysts' consensus estimates of $1.42 by $0.47. The firm had revenue of $1.92 billion during the quarter, compared to the consensus estimate of $1.84 billion. Chemours had a return on equity of 79.77% and a net margin of 12.72%. The company's quarterly revenue was up 15.7% compared to the same quarter last year. During the same period in the prior year, the company earned $1.20 EPS. On average, equities research analysts anticipate that Chemours will post 5.6 earnings per share for the current year.

Chemours Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 15th. Investors of record on Monday, August 15th will be given a $0.25 dividend. The ex-dividend date of this dividend is Friday, August 12th. This represents a $1.00 dividend on an annualized basis and a yield of 2.71%. Chemours's dividend payout ratio is presently 18.66%.

Wall Street Analyst Weigh In

Several analysts have recently commented on CC shares. Royal Bank of Canada raised their price objective on shares of Chemours from $44.00 to $48.00 and gave the company an "outperform" rating in a research report on Monday, August 1st. StockNews.com upgraded shares of Chemours from a "buy" rating to a "strong-buy" rating in a research report on Friday, July 29th. Barclays upped their price target on Chemours from $37.00 to $46.00 in a research note on Monday, May 9th. Bank of America downgraded shares of Chemours from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $48.00 to $44.00 in a report on Tuesday, June 14th. Finally, Citigroup raised their target price on shares of Chemours to $36.00 in a research note on Tuesday, August 9th. Three investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $40.17.

Insider Buying and Selling

In related news, insider Edwin C. Sparks sold 22,142 shares of the firm's stock in a transaction on Tuesday, June 7th. The stock was sold at an average price of $43.59, for a total value of $965,169.78. Following the completion of the sale, the insider now directly owns 101,038 shares in the company, valued at $4,404,246.42. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 3.04% of the stock is owned by corporate insiders.

Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Stock News Headlines

Citigroup Boosts Chemours (NYSE:CC) Price Target to $36.00
Chemours (NYSE:CC) PT Raised to $48.00 at Royal Bank of Canada
Chemours (NYSE:CC) Rating Reiterated by Royal Bank of Canada
CC vs. ALB: Which Stock Is the Better Value Option?
Chemours (NYSE:CC) Lifted to "Strong-Buy" at StockNews.com
Chemours (NYSE:CC) Is Paying Out A Dividend Of $0.25
Chemours (NYSE:CC) PT Raised to $37.00
See More Headlines
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Company Calendar

Ex-Dividend for 6/15 Dividend
5/13/2022
Dividend Payable
6/15/2022
Last Earnings
7/28/2022
Ex-Dividend for 9/15 Dividend
8/12/2022
Today
8/19/2022
Dividend Payable
9/15/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Fax
N/A
Employees
6,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$40.17
High Stock Price Forecast
$48.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+9.3%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$608 million
Pretax Margin
15.03%

Debt

Sales & Book Value

Annual Sales
$6.35 billion
Cash Flow
$6.17 per share
Book Value
$7.83 per share

Miscellaneous

Free Float
150,422,000
Market Cap
$5.70 billion
Optionable
Optionable
Beta
1.82

Key Executives

  • Mr. Mark E. NewmanMr. Mark E. Newman (Age 59)
    CEO, Pres & Director
    Comp: $2.5M
  • Mr. Sameer  RalhanMr. Sameer Ralhan (Age 48)
    Sr. VP & CFO
    Comp: $1.55M
  • Mr. David C. Shelton Esq.Mr. David C. Shelton Esq. (Age 58)
    Sr. VP, Gen. Counsel & Corp. Sec.
    Comp: $1.17M
  • Ms. Susan M. Kelliher (Age 55)
    Sr. VP of People
    Comp: $955.72k
  • Mr. Edwin C. SparksMr. Edwin C. Sparks (Age 48)
    Pres of Titanium Technologies & Chemical Solutions
    Comp: $1.32M
  • Ms. Camela T. Wisel (Age 47)
    VP, Chief Accounting Officer & Controller
  • Kurt Bonner
    Mang. of Investor Relations
  • Ms. Alvenia  ScarboroughMs. Alvenia Scarborough (Age 48)
    Sr. VP of Corp. Communications & Chief Brand Officer
  • Ms. Alisha  BellezzaMs. Alisha Bellezza (Age 46)
    Pres of Thermal & Specialized Solutions
  • Mr. Jonathan S. Lock (Age 41)
    Section 16 Officer, Sr. VP & Chief Devel. Officer













CC Stock - Frequently Asked Questions

Should I buy or sell Chemours stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View CC analyst ratings
or view top-rated stocks.

What is Chemours' stock price forecast for 2022?

4 brokerages have issued 12-month price objectives for Chemours' stock. Their CC share price forecasts range from $30.00 to $48.00. On average, they predict the company's stock price to reach $40.17 in the next twelve months. This suggests a possible upside of 8.0% from the stock's current price.
View analysts price targets for CC
or view top-rated stocks among Wall Street analysts.

How have CC shares performed in 2022?

Chemours' stock was trading at $33.56 on January 1st, 2022. Since then, CC stock has increased by 10.8% and is now trading at $37.19.
View the best growth stocks for 2022 here
.

When is Chemours' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our CC earnings forecast
.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) issued its quarterly earnings results on Thursday, July, 28th. The specialty chemicals company reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.47. The specialty chemicals company earned $1.92 billion during the quarter, compared to analyst estimates of $1.84 billion. Chemours had a net margin of 12.72% and a trailing twelve-month return on equity of 79.77%. The business's quarterly revenue was up 15.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.20 EPS.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours announced a quarterly dividend on Thursday, July 28th. Investors of record on Monday, August 15th will be given a dividend of $0.25 per share on Thursday, September 15th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.69%. The ex-dividend date is Friday, August 12th.
Read our dividend analysis for CC
.

Is Chemours a good dividend stock?

Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 2.74%. The dividend payout ratio is 18.66%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CC will have a dividend payout ratio of 16.72% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CC.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Who are Chemours' major shareholders?

Chemours' stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (8.03%), State Street Corp (2.87%), Northern Trust Corp (1.10%), AQR Capital Management LLC (0.84%), Massachusetts Financial Services Co. MA (0.74%) and Vaughan Nelson Investment Management L.P. (0.71%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, E Bryan Snell, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Richard H Brown and Sameer Ralhan.
View institutional ownership trends
.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $37.19.

How much money does Chemours make?

Chemours (NYSE:CC) has a market capitalization of $5.77 billion and generates $6.35 billion in revenue each year. The specialty chemicals company earns $608 million in net income (profit) each year or $5.36 on an earnings per share basis.

How many employees does Chemours have?

The company employs 6,400 workers across the globe.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The official website for the company is www.chemours.com. The specialty chemicals company can be reached via phone at (302) 773-1000 or via email at investor@chemours.com.

This page (NYSE:CC) was last updated on 8/19/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.